Stock Report

Download full stock data and analysis for free Last Updated: 02-Sep-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Sinovac Biotech - ADR Key Ratios

Stock Card factsheet share-fund-plan-icon

$6.47

$0.00 (0.00%)

As on 07-Jul-2026 16:00EDT

Market cap

info icon

$642 Mln

Revenue (TTM)

info icon

$-- Mln

P/E Ratio

info icon

6.7

P/B Ratio

info icon

1.8

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- 6.82 -36.29 -5.44
EBIT -- -- -- -322.35 -206.25
Net Profit -- -- -165.65 -180.63 -188.43
EPS -- -- -165.65 -180.60 -190.80
Book Value -- -- -46.27 -20.79 46.66
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsDec-25Dec-24Dec-23
EBIT-Margin info -54.55-4.18-75.47---33.63
Net Margin info ----------
Return on equity info -0.3333.67-0.941.07-1.13
Return on Capital info -0.3232.76-0.901.05-1.11
Return on Assets info -0.2018.19-0.570.70-0.72
Debt to Equity (x) info ----0.11--0.03

Profitability

View Detailed Peer Comparison

ROCE

-0.90

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Sinovac Biotech - ADR
-0.90
1.05
-1.11
1.23
163.54
Peer Median
--
--
--
--
--
ROE

-0.94

--

Profit after tax / Average Net worth * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Sinovac Biotech - ADR
-0.94
1.07
-1.13
1.25
168.11
Peer Median
--
--
--
--
--
ROA

-0.57

--

Profit after tax / Average Total assets * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Sinovac Biotech - ADR
-0.57
0.70
-0.72
0.74
90.81
Peer Median
--
--
--
--
--
EBIT Margin

-75.47

--

Operating profit (EBIT) / Net Sales * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Sinovac Biotech - ADR
-75.47
--
-33.63
1.78
90.59
Peer Median
--
--
--
--
--
Net Margin

-15.46

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Sinovac Biotech - ADR
-15.46
25.16
-22.29
7.63
43.70
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

Revenue Growth

0.07

--

Year on year growth in net sales

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Sinovac Biotech - ADR
0.07
-0.19
-0.70
-0.92
36.94
Peer Median
--
--
--
--
--
EBIT Growth

--

--

Year on year growth in operating profit (EBIT)

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Sinovac Biotech - ADR
--
--
-668.92
-99.85
8,058.65
Peer Median
--
--
--
--
--
Net Profit Growth

-165.65

--

Year on year growth in profit after tax

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Sinovac Biotech - ADR
-165.65
190.98
-187.75
-98.66
7,571.97
Peer Median
--
--
--
--
--
EPS Growth

-1.66

--

Year on year growth in earnings per share

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Sinovac Biotech - ADR
-1.66
1.91
-1.88
-0.98
75.50
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

0.11

--

Total debt / Net worth

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Sinovac Biotech - ADR
0.11
--
0.03
0.01
0.02
Peer Median
--
--
--
--
--
Short term debt to equity ratio

0.05

--

(Short term borrowings / Net worth)

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Sinovac Biotech - ADR
0.05
--
0.01
0.00
0.00
Peer Median
--
--
--
--
--
Current Ratio

4.59

--

Current Assets / Current Liabilities and Provisions

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Sinovac Biotech - ADR
4.59
7.33
10.31
11.11
6.18
Peer Median
--
--
--
--
--
Quick Ratio

4.53

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Sinovac Biotech - ADR
4.53
7.26
10.18
10.94
6.03
Peer Median
--
--
--
--
--
Interest Coverage

-29.67

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Sinovac Biotech - ADR
-29.67
--
-66.71
20.97
6,189.10
Peer Median
--
--
--
--
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

81.11

--

Debtors outstanding / Net Sales * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Sinovac Biotech - ADR
81.11
83.26
100.55
40.83
4.92
Peer Median
--
--
--
--
--
Asset Turnover

0.04

--

Sales / Average Total Assets

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Sinovac Biotech - ADR
0.04
0.03
0.03
0.10
2.08
Peer Median
--
--
--
--
--
Receivable days

290.47

--

Average Debtors / Sales * 365

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Sinovac Biotech - ADR
290.47
379.84
431.93
191.08
11.37
Peer Median
--
--
--
--
--
Inventory Days

281.57

--

Average Inventory / Sales * 365

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Sinovac Biotech - ADR
281.57
307.38
322.55
148.41
81.98
Peer Median
--
--
--
--
--
Payable days

41.93

--

Average Creditors / Cost of goods sold * 365

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Sinovac Biotech - ADR
41.93
38.35
37.34
20.92
15.18
Peer Median
--
--
--
--
--
Cash Conversion Cycle

530.11

--

Receivable Days + Inventory Days - Payable Days

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Sinovac Biotech - ADR
530.11
648.87
717.14
318.57
78.17
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

Price / Earnings

-10.80

--

Current share price divided by earning per share in the last twelve months

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Sinovac Biotech - ADR
-10.80
7.09
-6.45
--
0.09
Peer Median
--
--
--
--
--
Price / Book Value

0.15

--

Current share price divided by book value per share in the latest financial year

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Sinovac Biotech - ADR
0.15
0.08
0.07
--
0.08
Peer Median
--
--
--
--
--
EV/EBITDA

29.25

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Sinovac Biotech - ADR
29.25
--
1,705.05
--
-0.71
Peer Median
--
--
--
--
--
loading...
loading...